PATH insider buying and SEC filings, explained
UiPath, Inc. · CIK 1734722
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$0
Planned sales (10b5-1)
$89.2M
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Oct 22, 2026 | Planned (10b5-1) | Raghavendra Malpani (CPO & CTO) sold 29,565 shares at $14.00 ($414K), marked as a 10b5-1 plan trade. Holdings down 2% to 1,484,716 shares. | SEC filing Filed Oct 26, 2026, 4:31 PM ET |
| Oct 15–16, 2026 | Planned (10b5-1) | Daniel Dines (CEO and Director) sold 2,500,000 shares between Oct 15 and Oct 16 at about $13.23 ($33.1M), marked as a 10b5-1 plan trade. Holdings down 8% to 28,991,238 shares. | SEC filing Filed Oct 19, 2026, 4:26 PM ET |
| Oct 12, 2026 | Planned (10b5-1) | Brad Brubaker (Chief Legal & Admin Officer) sold 27,404 shares at $13.63 ($374K), marked as a 10b5-1 plan trade. Holdings down 3% to 1,066,107 shares. | SEC filing Filed Oct 13, 2026, 4:20 PM ET |
| Oct 9, 2026 | Planned (10b5-1) | Raghavendra Malpani (CPO & CTO) sold 29,564 shares at $13.51 ($399K), marked as a 10b5-1 plan trade. Holdings down 2% to 1,514,281 shares. | SEC filing Filed Oct 13, 2026, 4:20 PM ET |
| Oct 2, 2026 | Planned (10b5-1) | Ashim Gupta (President / COO) sold 66,052 shares at $13.17 ($870K), marked as a 10b5-1 plan trade. Holdings down 3% to 1,902,434 shares. | SEC filing Filed Oct 5, 2026, 4:33 PM ET |
| Sep 17, 2026 | Planned (10b5-1) | Raghavendra Malpani (CPO & CTO) sold 40,464 shares at $14.00 ($566K), marked as a 10b5-1 plan trade. Holdings down 2% to 1,582,213 shares. | SEC filing Filed Sep 21, 2026 |
| Sep 16, 2026 | Planned (10b5-1) | Raghavendra Malpani (CPO & CTO) sold 98,429 shares at $13.81 ($1.4M), marked as a 10b5-1 plan trade. Holdings down 6% to 1,622,677 shares. | SEC filing Filed Sep 17, 2026 |
| Sep 11, 2026 | Planned (10b5-1) | Ashim Gupta (President / COO) sold 117,339 shares at $13.85 ($1.6M), marked as a 10b5-1 plan trade. Holdings down 5% to 2,037,377 shares. | SEC filing Filed Sep 14, 2026 |
| Aug 19, 2026 | Planned (10b5-1) | Daniel Dines (CEO and Director) sold 1,402,347 shares at $16.07 ($22.5M), marked as a 10b5-1 plan trade. Holdings down 5% to 26,491,238 shares. | SEC filing Filed Aug 19, 2026 |
| Aug 13–14, 2026 | Planned (10b5-1) | Hitesh Ramani (Chief Accounting Officer) sold 50,000 shares between Aug 13 and Aug 14 at about $16.63 ($831K), marked as a 10b5-1 plan trade. Holdings down 18% to 235,052 shares. | SEC filing Filed Aug 14, 2026 |
| Jan 22–26, 2026 | Planned (10b5-1) | Daniel Dines (CEO and Director) sold 135,000 shares between Jan 22 and Jan 26 at about $15.09 ($2.0M), marked as a 10b5-1 plan trade. Holdings down <1% to 27,893,585 shares. | SEC filing Filed Jan 26, 2026 |
| Jan 15, 2026 | Planned (10b5-1) | Daniel Dines (CEO and Director) sold 45,000 shares at $15.38 ($692K), marked as a 10b5-1 plan trade. Holdings down <1% to 28,028,585 shares. | SEC filing Filed Jan 15, 2026 |
| Jan 14, 2026 | Planned (10b5-1) | Daniel Dines (CEO and Director) sold 45,000 shares at $15.68 ($706K), marked as a 10b5-1 plan trade. Holdings down <1% to 28,073,585 shares. | SEC filing Filed Jan 14, 2026 |
| Jan 13, 2026 | Planned (10b5-1) | Daniel Dines (CEO and Director) sold 45,000 shares at $17.18 ($773K), marked as a 10b5-1 plan trade. Holdings down <1% to 28,118,585 shares. | SEC filing Filed Jan 13, 2026 |
| Jan 12, 2026 | Planned (10b5-1) | Daniel Dines (CEO and Director) sold 45,000 shares at $16.61 ($747K), marked as a 10b5-1 plan trade. Holdings down <1% to 28,163,585 shares. | SEC filing Filed Jan 12, 2026 |
| Jan 9, 2026 | Planned (10b5-1) | Daniel Dines (CEO and Director) sold 45,000 shares at $17.17 ($773K), marked as a 10b5-1 plan trade. Holdings down <1% to 28,208,585 shares. | SEC filing Filed Jan 9, 2026 |
| Jan 8, 2026 | Planned (10b5-1) | Daniel Dines (CEO and Director) sold 45,000 shares at $17.49 ($787K), marked as a 10b5-1 plan trade. Holdings down <1% to 28,253,585 shares. | SEC filing Filed Jan 8, 2026 |
| Jan 7, 2026 | Planned (10b5-1) | Daniel Dines (CEO and Director) sold 45,000 shares at $17.32 ($779K), marked as a 10b5-1 plan trade. Holdings down <1% to 28,298,585 shares. | SEC filing Filed Jan 7, 2026 |
| Jan 6, 2026 | Planned (10b5-1) | Daniel Dines (CEO and Director) sold 45,000 shares at $15.99 ($720K), marked as a 10b5-1 plan trade. Holdings down <1% to 28,343,585 shares. | SEC filing Filed Jan 6, 2026 |
| Jan 5, 2026 | Planned (10b5-1) | Ashim Gupta (CFO) sold 67,468 shares at $16.10 ($1.1M), marked as a 10b5-1 plan trade. Holdings down 11% to 557,028 shares. | SEC filing Filed Jan 6, 2026 |
| Oct 22, 2025 | Planned (10b5-1) Amended filing | Hitesh Ramani (Chief Accounting Officer) sold 5,000 shares at $15.47 ($77K), marked as a 10b5-1 plan trade. Holdings down 3% to 187,776 shares. This amends a filing from Oct 22, 2025. | SEC filing Filed Jan 6, 2026 |
| Jan 5, 2026 | Planned (10b5-1) | Daniel Dines (CEO and Director) sold 45,000 shares at $15.73 ($708K), marked as a 10b5-1 plan trade. Holdings down <1% to 28,388,585 shares. | SEC filing Filed Jan 5, 2026 |
| Jan 2, 2026 | Planned (10b5-1) | Daniel Dines (CEO and Director) sold 45,000 shares at $16.38 ($737K), marked as a 10b5-1 plan trade. Holdings down <1% to 28,433,585 shares. | SEC filing Filed Jan 2, 2026 |
| Dec 30–31, 2025 | Planned (10b5-1) | Daniel Dines (CEO and Director) sold 90,000 shares between Dec 30, 2025 and Dec 31, 2025 at about $16.69 ($1.5M), marked as a 10b5-1 plan trade. Holdings down <1% to 28,478,585 shares. | SEC filing Filed Dec 31, 2025 |
| Dec 24–29, 2025 | Planned (10b5-1) | Daniel Dines (CEO and Director) sold 135,000 shares between Dec 24, 2025 and Dec 29, 2025 at about $16.75 ($2.3M), marked as a 10b5-1 plan trade. Holdings down <1% to 28,568,585 shares. | SEC filing Filed Dec 29, 2025 |
| Dec 22–23, 2025 | Planned (10b5-1) | Daniel Dines (CEO and Director) sold 90,000 shares between Dec 22, 2025 and Dec 23, 2025 at $16.49 ($1.5M), marked as a 10b5-1 plan trade. Holdings down <1% to 28,703,585 shares. | SEC filing Filed Dec 23, 2025 |
| Dec 19, 2025 | Planned (10b5-1) | Daniel Dines (CEO and Director) sold 45,000 shares at $16.07 ($723K), marked as a 10b5-1 plan trade. Holdings down <1% to 28,793,585 shares. | SEC filing Filed Dec 19, 2025 |
| Dec 18, 2025 | Planned (10b5-1) | Daniel Dines (CEO and Director) sold 45,000 shares at $16.23 ($730K), marked as a 10b5-1 plan trade. Holdings down <1% to 28,838,585 shares. | SEC filing Filed Dec 18, 2025 |
| Dec 17, 2025 | Planned (10b5-1) | Daniel Dines (CEO and Director) sold 45,000 shares at $16.11 ($725K), marked as a 10b5-1 plan trade. Holdings down <1% to 28,883,585 shares. | SEC filing Filed Dec 17, 2025 |
| Dec 16, 2025 | Planned (10b5-1) | Daniel Dines (CEO and Director) sold 45,000 shares at $16.26 ($732K), marked as a 10b5-1 plan trade. Holdings down <1% to 28,928,585 shares. | SEC filing Filed Dec 16, 2025 |
| Dec 12–15, 2025 | Planned (10b5-1) | Daniel Dines (CEO and Director) sold 90,000 shares between Dec 12, 2025 and Dec 15, 2025 at about $17.61 ($1.6M), marked as a 10b5-1 plan trade. Holdings down <1% to 28,973,585 shares. | SEC filing Filed Dec 15, 2025 |
| Dec 11, 2025 | Planned (10b5-1) | Daniel Dines (CEO and Director) sold 45,000 shares at $18.56 ($835K), marked as a 10b5-1 plan trade. Holdings down <1% to 29,063,585 shares. | SEC filing Filed Dec 11, 2025 |
| Dec 10, 2025 | Planned (10b5-1) | Daniel Dines (CEO and Director) sold 45,000 shares at $18.61 ($837K), marked as a 10b5-1 plan trade. Holdings down <1% to 29,108,585 shares. | SEC filing Filed Dec 10, 2025 |
| Dec 9, 2025 | Planned (10b5-1) | Daniel Dines (CEO and Director) sold 45,000 shares at $19.13 ($861K), marked as a 10b5-1 plan trade. Holdings down <1% to 29,153,585 shares. | SEC filing Filed Dec 9, 2025 |
| Dec 8, 2025 | Planned (10b5-1) | Daniel Dines (CEO and Director) sold 45,000 shares at $19.21 ($864K), marked as a 10b5-1 plan trade. Holdings down <1% to 29,198,585 shares. | SEC filing Filed Dec 8, 2025 |
| Dec 5, 2025 | Planned (10b5-1) | Brad Brubaker (GC & Chief Legal Officer) sold 27,580 shares at $18.55 ($512K), marked as a 10b5-1 plan trade. Holdings down 4% to 635,359 shares. | SEC filing Filed Dec 8, 2025 |
| Dec 5, 2025 | Planned (10b5-1) | Daniel Dines (CEO and Director) sold 45,000 shares at $18.20 ($819K), marked as a 10b5-1 plan trade. Holdings down <1% to 29,243,585 shares. | SEC filing Filed Dec 5, 2025 |
| Nov 5, 2025 | Planned (10b5-1) | Daniel Dines (CEO and Director) sold 45,000 shares at $15.07 ($678K), marked as a 10b5-1 plan trade. Holdings down <1% to 29,288,585 shares. | SEC filing Filed Nov 5, 2025 |
| Nov 4, 2025 | Planned (10b5-1) | Daniel Dines (CEO and Director) sold 45,000 shares at $15.02 ($676K), marked as a 10b5-1 plan trade. Holdings down <1% to 29,333,585 shares. | SEC filing Filed Nov 4, 2025 |
| Nov 3, 2025 | Planned (10b5-1) | Daniel Dines (CEO and Director) sold 45,000 shares at $16.23 ($730K), marked as a 10b5-1 plan trade. Holdings down <1% to 29,378,585 shares. | SEC filing Filed Nov 3, 2025 |
35 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow PATH in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.